Recently, using data from Tysabri Outreach: Unified Commitment to Health, a programme stimulated by the US Food and Drug Administration, NTZ-extended dosing schedules have been found to significantly reduce the PML risk.2 In this issue, Chisari and colleagues reported the results of a multicentre ...